Safety and efficacy results of durvalumab following sequential chemoradiotherapy (sCRT) in unresectable stage III NSCLC (PACIFIC 6)
Authors
Heilmann, M.Garassino, M. C.
Mazieres, J.
Chouaid, C.
Bischoff, H.
Reinmuth, N.
Cove Smith, L.
Mansy, T.
Cortinovis, D.
Migliorino, M. R.
Delmonte, A.
Sanchez, J. G.
Velarde, L. E. C.
Bernabe, R.
Paz Ares, L.
Perez, D. I.
Trunova, N.
Foroutanpour, K.
Faivre-Finn, Corinne
Reck, M.
Affiliation
RH Klinikum Siloah, Pneumologie, Intensiv und Schlafmedizin, Hannover, DeutschlandIssue Date
2022